FMR1 and fragile X syndrome: FMRP binds and acts as a repressor of translation of a number of mRNAs including those involved in the ERK cascade signaling pathway [74]; thus, the lack of this negative translational control is believed to lead to upregulation of these pathways and consequently to the altered synaptogenesis observed in FXS.